| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Loss before income taxes | -8,847 | -6,450 | ||
| Income tax expense | 132 | 59 | ||
| Net loss | -8,979 | -6,509 | ||
| Net loss per share - basic | -0.2 | -0.16 | ||
| Net loss per share - diluted | -0.2 | -0.16 | ||
| Weighted average number of shares outstanding, diluted | 45,801,927 | 39,935,213 | ||
| Weighted average ordinary shares outstanding - basic | 45,801,927 | 39,935,213 | ||
Iterum Therapeutics plc (ITRM)
Iterum Therapeutics plc (ITRM)